Browse drugs

…onclusions This hypothesis-generating study suggests that early belimumab use may rapidly delay damage in SLE. Future research is needed …

…nd plasma exchange was given without efficacy so treatment with obinutuzumab plus cyclophosphamide was initiated, with gradual neurological …

… class IV. She was treated with pulse IV Solumedrol followed by prednisone taper, HCQ, MMF and later one, MMF was switched to azathioprine…

…Objectives Belimumab (BEL) is an IgG1 antibody against the soluble form of B-cell ac…

…plained approximately 8% of the variance in δCLASI (R2 = 0.08). Anifrolumab was the only therapy independently associated with significant …

…sant; 3/5 rituximab and 4/5 belimumab. Concomitant therapy: 5/5 hydroxychloroquine, 4/5 MMF/Na, 5/5 prednisone (mean baseline dose 15 mg/day (10-1…

…ndings suggest potential renal protective effects through which belimumab may prevent progression to LN.Funding: GSKOriginal presentation…

…ling is a central driver of systemic lupus erythematosus (SLE). Anifrolumab, an anti-IFNAR1 monoclonal antibody, improves outcomes in moder…

…ron pathway and neutrophil, myeloid cell and B cell activation. Enpatoran is a novel, first-in-class, oral TLR7/8 inhibitor. In a Phase 2…

…tively.Conclusion From a Chinese healthcare system perspective, sugemalimab plus chemotherapy as first-line treatment for advanced ESCC mig…

…Background Cannabis use is far more common among adults who smoke tobacco than adul…

…es (PROs) in patients with rheumatoid arthritis (RA) initiating tofacitinib in a real-world setting.Design The non-interventional study ESC…